Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis
The aim of this study was to evaluate the efficacy of oral transmucosal (OTM) cannabidiol (CBD), in addition to a multimodal pharmacological treatment for chronic osteoarthritis-related pain in dogs. Twenty-one dogs were randomly divided into two groups: in group CBD (<i>n</i> = 9), OTM...
Main Authors: | Federica Alessandra Brioschi, Federica Di Cesare, Daniela Gioeni, Vanessa Rabbogliatti, Francesco Ferrari, Elisa Silvia D’Urso, Martina Amari, Giuliano Ravasio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/10/9/1505 |
Similar Items
-
Evaluation of an oral transmucosal administration of dexmedetomidine-butorphanol and dexmedetomidine-methadone in dogs.
by: Daniela Gioeni, et al.
Published: (2017-05-01) -
Oral Transmucosal or Intramuscular Administration of Dexmedetomidine–Methadone Combination in Dogs: Sedative and Physiological Effects
by: Daniela Gioeni, et al.
Published: (2020-11-01) -
RANGE AND CHARACTERISTICS TRANSMUCOSAL DOSAGE FORMS
by: N. V. Shestakov, et al.
Published: (2019-01-01) -
The application of oral transmucosal fentanyl for the treatment of breakthrough pain in cancer patients
by: D V Nevzorova, et al.
Published: (2017-06-01) -
Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
by: Arturo Cuomo, et al.
Published: (2020-04-01)